The permeability transition pore complex: A target for apoptosis regulation by caspases and Bcl-2-related proteins

Journal of Experimental Medicine

Volumn 187, Issue 8, 1998, Pages 1261-1271

  Marzo, Isabel ^a   Brenner, Catherine ^a   Zamzami, Naoufal ^a   Susin, Santos A ^a   Beutner, Gisela ^b   Brdiczka, Dieter ^b   Rémy, René ^a   Xie, Zhi Hua ^c   Reed, John C ^c   Kroemer, Guido ^a,d  

^a CNRS   (France)

^b UNIVERSITY OF KONSTANZ   (Germany)

^c BURNHAM INSTITUTE   (United States)

^d Burnham Institute ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CYCLOPHILIN; CYCLOSPORIN A; CYCLOSPORIN A DERIVATIVE; CYTOCHROME C; GENE PRODUCT; INTERLEUKIN 1BETA CONVERTING ENZYME; LIPOSOME; PROTEIN BCL 2; RECOMBINANT PROTEIN;

APOPTOSIS; ARTICLE; CELL DEATH; ENZYME ACTIVATION; MEMBRANE PERMEABILITY; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; PROTO ONCOGENE; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; BCL-X PROTEIN; BRAIN; CYSTEINE ENDOPEPTIDASES; LIPOSOMES; MEMBRANE PROTEINS; MICE; MITOCHONDRIA; PERMEABILITY; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS;

EID: 0032550363     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.187.8.1261     Document Type: Article

References (63)

1. Zamzami, N., P. Marchetti, M. Castedo, C. Zanin, J.-L. Vayssière, P.X. Petit, and G. Kroemer. 1995. Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. J. Exp. Med. 181: 1661-1672.
2. Zamzami, N., P. Marchetti, M. Castedo, U. Decaudin, A. Macho, T. Hirsch, S.A. Susin, P.X. Petit, B. Mignotte, and G. Kroemer. 1995. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. J. Exp. Med. 182: 367-377.
3. Kroemer, G., N. Zamzami, and S.A. Susin. 1997. Mitochondrial control of apoptosis. Immunol. Today. 18:44-51.
4. Kroemer, G. 1997. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat. Med. 3:614-620.
5. Liu, X., C.N. Kim, J. Yang, R. Jemmerson, and X. Wang. 1996. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell. 86:147-157.
6. Yang, J., X. Liu, K. Bhalla, C.N. Kim, A.M. Ibrado, J. Cai, T.-I. Peng, D.P. Jones, and X. Wang. 1997. Prevention of apoptosis by Bcl-2: release ot cytochrome c from mitochondria blocked. Science. 275:1129-1132.
7. Kluck, R.M., E. Bossy-Wetzel, D.R. Green, and D.D. Newmeyer. 1997. The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science. 275:1132-1136.
8. Zamzami, N., S.A. Susin, P. Marchetti, T. Hirsch, I. Gómez-Monterrey, M. Castedo, and G. Kroemer. 1996. Mitochondrial control of nuclear apoptosis. J. Exp. Med. 183:1533-1544.
9. Susin, S.A., N. Zamzami, M. Castedo, T. Hirsch, P. Marchetti, A. Macho, E. Daugas, M. Geuskens, and G. Kroemer. 1996. Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J. Exp. Med. 184:1331-1342.
10. Reed, J.C. 1997. Double identity for proteins of the Bcl-2 family. Nature. 387:773-776.
11. Marchetti, P., M. Castedo, S.A. Susin, N. Zamzami, T. Hirsch, A. Haeffner, F. Hirsch, M. Geuskens, and G. Kroemer. 1996. Mitochondrial permeability transition is a central coordinating event of apoptosis. J. Exp. Med. 184:1155-1160.
12. Zoratti, M., and I. Szabò. 1995. The mitochondrial permeability transition. Biochim. Biophys. Acta Rev. Biomembranes. 1241: 139-176.
13. Bernardi, P., and V. Petronilli. 1996. The permeability transition pore as a mitochondrial calcium release channel: a critical appraisal. J. Bioenerg. Biomembr. 28:129-136.
14. Kantrow, S.P., and C.A. Piantadosi. 1997. Release of cytochrome c from liver mitochondria during permeability transition. Biochem. Biophys. Res. Commun. 232:669-671.
15. Ellerby, H.M., S.J. Martin, L.M. Ellerby, S.S. Naiem, S. Rabizadeh, G.S. Salvese, C.A. Casiano, N.R. Cashman, D.R. Green, and D.E. Bredesen. 1997. Establishment of a cell-free system of neuronal apoptosis: comparison of premitochondrial, mitochondrial, and postmitochondrial phases. J. Neurosci. 17:6165-6178.
16. Griffiths, E.J., and A.P. Halestrup. 1993. Protection by cyclosporin A of ischemia/reperfusion-induced damage in isolated rat hearts. J. Mol. Cell. Cardiol. 25:1461-1469.
17. Trost, L.C., and J.J. Lemasters. 1996. The mitochondrial permeability transition: a new pathophysioligal mechanism for Reye's syndrome and toxic liver injury. J. Pharmacol. Exp. Ther. 278:1000-1005.
18. Schinder, A.F., E.C. Olson, N.C. Spitzer, and M. Montal. 1996. Mitochondrial dysfunction is a primary event in glutamate neurotoxicity. J. Neurosci. 16:6125-6133.
19. Ichas, F., L.S. Jouavill, and J.-P. Mazat. 1997. Mitochondria are excitable organelles capable of generating and conveying electric and calcium currents. Cell. 89:1145-1153.
20. Nicolli, A., E. Basso, V. Petronilli, R.M. Wenger, and P. Bernardi. 1996. Interactions ot cyclophilin with mitochondrial inner membrane and regulation of the permeability transition pore, a cyclosporin A-sensitive channel. J. Biol. Chem. 271:2185-2192.
21. Brustovetsky, N., and M. Klingenberg. 1996. Mitochondrial ADP/ATP carrier can be reversibly converted into a large channel by Ca2+. Biochemistry. 35:8483-8488.
22. Beutner, G., A. Rück, B. Riede, W. Welte, and D. Brdiczka. 1996. Complexes between kinases, mitochondrial porin, and adenylate translocator in rat brain resemble the permeability transition pore. FEBS Lett. 396:189-195.
23. Halestrup, A.P., K.-Y. Woodfield, and C.P. Connern. 1997. Oxidative stress, thiol reagents, and membrane potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide translocator. J. Biol. Chem. 272:3346-3354.
24. White, K.J., and I.J. Reynolds. 1996. Mitochondrial depolarization in glutamate-stimulated neurons: an early signal specific to excitotoxin exposure. J. Neurosci. 16:5688-5697.
25. Pastorino, J.G., G. Simbula, K. Yamamoto, P.A.J. Glascott, R.J. Rothman, and J.L. Farber. 1996. The cytotoxicity of tumor necrosis factor depends on induction of the mitochondrial permeability transition. J. Biol. Chem. 271:29792-29799.
26. Susin, S.A., N. Zamzami, M. Castedo, E. Daugas, H.-G. Wang, S. Geley, F. Fassy, J. Reed, and G. Kroemer. 1997. The central executioner of apoptosis. Multiple links between protease activation and mitochondria in Fas/Apo-1/CD95- and ceramide-induced apoptosis. J. Exp. Med. 186:25-37.
27. Hortelano, S., U. Dallaporta, N. Zamzami, T. Hirsch, S.A. Susin, I. Marzo, L. Bosca, and G. Kroemer. 1997. Nitric oxide induces apoptosis via triggering mitochondrial permeability transition. FEBS Lett. 410:373-377.
28. Shimizu, S., Y. Eguchi, W. Kamiike, S. Waguri, Y. Uchiyama, H. Matsuda, and Y. Tsujimoto. 1996. Bcl-2 blocks loss of mitochondrial membrane potential while ICE inhibitors act at a different step during inhibition of death induced by respiratory chain inhibitors. Oncogene. 13:21-29.
29. Decaudin, D., S. Geley, T. Hirsch, M. Castedo, P. Marchetti, A. Macho, K. Kofler, and G. Kroemer. 1997. Bcl-2 and Bcl-XL antagonize the mitochondrial dysfunction preceding nuclear apoptosis induced by chemotherapeutic agents. Cancer Res. 57:62-67.
30. Boise, L.H., and C.H. Thompson. 1997. Bcl-XL can inhibit apoptosis in cells that have undergone Fas-induced protease activation. Proc. Natl. Acad. Sci. USA. 94:3759-3764.
31. Kim, C.N., X.U. Wang, Y. Huang, A.M. Ibrado, L. Liu, G.F. Fang, and K. Bhalla. 1997. Overexpression of Bcl-x(L), inhibits Ara-C-induced mitochondrial loss of cytochrome c and other perturbations that activate the molecular cascade of apoptosis. Cancer Res. 57:3115-3120.
32. Xiang, J., D.T. Chao, and S.J. Korsmeyer. 1996. Bax-induced cell death may not require interleukin 1beta-converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA. 93:14559-14563.
33. Minn, A.J., P. Vélez, S.L. Schendel, H. Liang, S.W. Muchmore, S.W. Fesik, M. Fill, and C.B. Thompson. 1997. Bcl-XL forms an ion channel in synthetic lipid membranes. Nature. 385:353-357.
34. Schendel, S., Z. Xie, M.U. Montal, S. Matsuyama, M. Montal, and J.C. Reed. 1997. Channel formation by antiapoptotic protein Bcl-2. Proc. Natl. Acad. Sci. USA. 94:5113-5118.
35. Antonsson, B., F. Conti, A. Ciavatta, S. Montessuit, S. Lewis, I. Martinou, M. Bernasconi, A. Bernard, J.-J. Mermod, G. Mazzei, et al. 1997. Inhibition of Bax channel-forming activity by Bcl-2. Science. 277:370-376.
36. Mittl, P.R.E., S. Dimarco, J.F. Krebs, X. Bai, D.S. Karanewsky, J.P. Priestle, K.J. Tomaselli, and M.G. Grutter. 1997. Structure of recombinant human CPP32 in complex with the tetrapeptide Aceryl-Asp-Val-Ala-Asp fluoromethyl ketone. J. Biol. Chem. 272:6539-6547.
37. Fernandes-Alnemri, T., R.C. Annstrong, J. Krebs, S.M. Srinivasula, L. Wang, F. Bullrich, L.C. Fritz, J.A. Trapani, K.J. Tomaselli, G. Litwack, and E.S. Alnemri. 1996. In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains. Proc. Natl. Acad. Sci. USA. 93:7464-7469.
38. Folch, J., M. Lees, and G.M.S. Stanley. 1957. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226:447-5116.
39. Colas des Francs-Small, C., F. Ambard-Bretteville, A. Darpas, M. Sallantin, J.-C. Huet, J.-C. Pernollet, and R. Rémy. 1992. Variation of the polypeptide composition ot mitochondria isolated from different potato tissues. Plant Physiol. (Lond.) 98:273-278.
40. Knull, H.R., W.F. Taylor, and W.W. Wells. 1973. Effects of energy metabolism on in vivo distribution ot hexokinase in brain. J. Biol. Chem. 248:5414-5417.
41. Arora, K.K., D.M. Parry, and P.L. Pedersen. 1992. Hexokinase receptors: preferential enzyme binding in normal cells to nonmitochondrial sites and in transformed cells to mitochondrial sites. J. Bioenerg. Biomembr. 24:47-53.
42. Gelb, B., V. Adams, S. Jones, L. Griffin, G. MacGregor, and E. McCabe. 1992. Targeting of hexokinase 1 to liver and hepatoma mitochondria. Proc. Natl. Acad. Sci. USA. 89:202-206.
43. O'Gorman, F., G. Beutner, M. Dolder, A.P. Koretsky, D. Brdiczka, and T. Wallimann. 1997. The role of creatine kinase in inhibition of mitochondrial permeability transition. FEBS Lett. 414:253-257.
44. Nieminen, A.L., A.M. Byrne, B. Herman, and J.I. Lemasters. 1997. Mitochondrial permeability transition induced by t-BuOOH: NAD(P)H and reactive oxygen species. Am. J. Physiol 41:C1286-C1294.
45. Rigaud, J.L., M.T. Paternostre, and A. Bluzat. 1988. Mechanisms of membrane protein insertion into liposomes during reconstitution procedures involving the use of detergents. 2. Incorporation of the light-driven proton pump bacteriorhodopsin. Biochemistry. 27:2677-2688.
46. New, R.R.C. 1990. Peparation of liposomes. In Liposomes: a Practical Approach. R.R.C. New, editor. Oxford University Press, Oxford. 33-104.
47. Murphy, A.N., D.E. Bredesen, G. Cortopassi, E. Wang, and G. Fiskum. 1996. Bcl-2 potentiates the maximal calcium uptake capacity of neural cell mitochondria. Proc. Natl. Acad. Sci. USA. 93:9893-9898.
48. Ying, X.M., Z.N. Oltvai, and S.J. Korsmeyer. 1994. BH1 and BH2 domains of Bcl-2 are required for inhibition of apoptosis and heterodimerization with Bax. Nature. 369:321-323.
49. Enari, M., R.V. Talaman, W.W. Wong, and S. Nagata. 1996. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature. 380:723-726.
50. Kuida, K., T.S. Zheng, S. Na, C.-Y. Kyan, D. Yang, H. Karasuyama, P. Rakic, and R.A. Flavell. 1996. Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature. 384:368-372.
51. Fraser, A., and G. Evan. 1996. A license to kill. Cell. 85: 781-784.
52. Kharbanda, S., P. Pandey, L. Schofield, S. Israels, R. Roncinske, K. Yoshida, A. Bharti, Z.-M. Yan, S. Saxena, R. Weichselbaum, et al. 1997. Role for Bcl-XL as an inhibitor of cytosolic cytochrome e accumulation in DNA damage-induced apoptosis. Proc. Natl. Acad. Sci. USA. 94:6939-6942.
53. vander Heiden, M.G., N.S. Chandal, E.K. Williamson, P.T. Schumacker, and C.B. Thompson. 1997. Bcl-XL regulates the membrane potential and volume homeostasis of mitochondria. Cell. 91:627-637.
54. Zhou, H., W.J. Henzel, X. Liu. A. Lutschg, and X. Wang. 1997. Apaf-1, a human protein homologous to C. elegans Ced-4. participates in cytochrome c-dependent activation of caspase-3. Cell. 90:405-413.
55. Strasser, A., A.W. Harris, D.C.S. Huang, P.H. Krammer, and S. Cory. 1995. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO (Eur. Mol. Biol. Organ.) J. 14:6136-6147.
56. Chiu, V.K., C.M. Walsh, L. Chau-Ching, J.G. Reed, and W.R. Clark. 1995. Bcl-2 blocks degranulation but not Fas-based cell-mediated cytotoxicity. J. Immunol. 154:2023-2029.
57. Memon, S.A., M.B. Moreno, D. Petrak, and C.M. Zacharchuk. 1995. Bcl-2 blocks glucocorticoid- but not Fas- or activation-induced apoptosis in a T cell hybridoma. J. Immunol. 155:4644-4652.
58. Huang, D.C.S., S. Cory, and A. Strasser. 1997. Bcl-2, Bcl-XL, and adenovirus protein E1B19kD are functionally equivalent in their ability to inhibit cell death. Oncogene. 14:405-414.
59. Miura, M., H. Zhu, R. Rotello, E.A. Hartwieg, and Y. Yan. 1993. Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3. Cell. 75:653-660.
60. Lacronique, V., A. Mignon, M. Fabre, B. Viollet, N. Rouquet, T. Molina, A. Porteu, A. Henrion, D. Bouscary, P. Varlet, et al. 1996. Bcl-2 protects from lethal hepatic apoptosis induced by an anti-Fas antibody in mice. Nat. Med. 2:80-86.
61. Cheng, E.H.Y., D.G. Kirsch, R.J. Clem, R. Ravi, M.B. Kastan, A. Bedi, K. Ueno, and J.M. Hardwick. 1997. Conversion of Bcl-2 to a Bax-like death effector by caspases. Science. 278:1966-1968.
62. Muchmore, S.W., M. Sattler, H. Liang, R.P. Meadows, J.E. Harlan, H.S. Yoon, D. Nettesheim, B.S. Chang, G.B. Thompson, S.-L. Wong, et al. 1996. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature. 381:335-341.
63. Martin, S.J., and D.R. Green. 1995. Protease activation during apoptosis: death by a thousand cuts? Cell. 82:349-352.